Although DZNep is an inhibitor of AdoHcy, in most of cancers it acts through the reduction of EZH2 level and in turn, the re-expression of genes silenced by PRC2 via the demethylation of K27H3 [13], [14], [37]. Here, EZH2 is linked to cancer.